Nasdaq chair and CEO Adena Friedman is still a believer in DEI initiatives, and in the IPO market coming back.

Even as FIIs consider valuations in the secondary market high, they remain upbeat on India's market narrative, compelling them to seize every opportunity, say experts.

Beta Bionics has set the terms for its plan to go public, with a goal of raising at least $114 million to support its ...

Nasdaq CEO Adena Friedman is optimistic that President Trump's administration will offer a chance to relook regulations in ...

Shares surged through the $40 level as the stock gained another 20%. Nano Nuclear shares are now trading 75& higher in 2025 ...

Rashaun Williams, Atlanta Falcons limited partner and venture capitalist, joined "Closing Bell" on CNBC to discuss his investment strategy and his outlook on the IPO market as 2025 ...

Axon Enterprise (NASDAQ: AXON) has been one of the most successful under-the-radar stock market investments of this century.

Cortigent, Inc CRGT IPO will take place January, 24 on the NASDAQ exchange under the ticker CRGT. The company is offering shares at an expected price between $9.00 and $11.00 per share with an insider ...

While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...

Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...

Nasdaq Chair and CEO Adena Friedman sees 2025 as a constructive year for new issuance and IPOs and discusses regulatory ...

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...